%0 Journal Article %A Kaitlyn E. Johnson %A Michael Lachmann %A Madison Stoddard %A Remy Pasco %A Spencer J. Fox %A Lauren Ancel Meyers %A Arijit Chakravarty %T Detecting in-school transmission of SARS-CoV-2 from case ratios and documented clusters %D 2021 %R 10.1101/2021.04.26.21256136 %J medRxiv %P 2021.04.26.21256136 %X Claims that in-person schooling has not amplified SARS-CoV-2 transmission are based on similar infection rates in schools and their surrounding communities and limited numbers of documented in-school transmission events. Simulations assuming high in-school transmission suggest that these metrics cannot exclude the possibility that transmission in schools exacerbated overall pandemic risks.Competing Interest StatementM.S. and A.C. are shareholders in Fractal Therapeutics. This does not alter our adherence to policies on sharing data and materials. Fractal Therapeutics intends to purse the development of prophylactics and therapeutics for SARS-CoV-2, but has no other business or financial interest in the topic of this paper. The remaining authors have declared no competing interest.Funding StatementWe acknowledge the financial support from NIH Grant R01 AI151176 and CDC Grant U01IP001136. M.S. received funding from Fractal Therapeutics for the duration of this project. The funding organization did not play a role in the study design, data analysis, decision to publish or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to is published data from a recent study: https://www.cdc.gov/mmwr/volumes/70/wr/mm7004e3.htm %U https://www.medrxiv.org/content/medrxiv/early/2021/04/28/2021.04.26.21256136.full.pdf